send mail to support@abhimanu.com mentioning your email id and mobileno registered with us! if details not recieved
Resend Opt after 60 Sec.
By Loging in you agree to Terms of Services and Privacy Policy
Claim your free MCQ
Please specify
Sorry for the inconvenience but we’re performing some maintenance at the moment. Website can be slow during this phase..
Please verify your mobile number
Login not allowed, Please logout from existing browser
Please update your name
Subscribe to Notifications
Stay updated with the latest Current affairs and other important updates regarding video Lectures, Test Schedules, live sessions etc..
Your Free user account at abhipedia has been created.
Remember, success is a journey, not a destination. Stay motivated and keep moving forward!
Refer & Earn
Enquire Now
My Abhipedia Earning
Kindly Login to view your earning
Support
Context: As part of an innovative step towards treatment of COVID-19 patients, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) has came up with “convalescent-plasma therapy”. What is convalescent-plasma therapy?
What are antibodies?
How the treatment is given?
Who will be receiving the treatment?
How is it different from vaccination?
What are the Challenges associated with this Therapy?
Is it effective?
Is it safe?
How long the antibodies will remain in the recipient?
Context: Recently, Kerala has got the Indian Council of Medical Research (ICMR) approval for the clinical protocol exploring the feasibility of convalescent plasma transfusion which may be administered to severe Covid-19 patients. Key Findings
About convalescent plasma therapy
Its working
By: Shubham Tiwari ProfileResourcesReport error
Access to prime resources
New Courses